Bryan Ridgell

Mr. Ridgell has over seventeen years of project management experience leading drug development projects and programs, including over ten years at ICON Clinical Research, where he held several positions in Project Management and gained experience working on numerous projects spanning a wide variety of compounds, indications and dosage forms. Prior to joining GlycoMimetics, Mr. Ridgell spent two years at Rexahn Pharmaceuticals as Director, Project Management. Mr. Ridgell joined GlycoMimetics in 2016 and has served as Director and Senior Director of Project Management, and was promoted in February 2022 to Vice President, Portfolio and Project Management. Mr. Ridgell is responsible for overseeing major project operations and ensuring key objectives are met with respect to scope, schedule, cost and quality. He is also accountable for implementing Project Management skills, tools and best practices across the organization. Mr. Ridgell is a Certified Project Management Professional (PMP) and member of the Project Management Institute since 2007. He holds a Master’s degree in Business Administration (MBA) from The Johns Hopkins University and B.S. degree in Marine and Environmental Chemistry from the Florida Institute of Technology.